Home LiteratureArticle Details
PMID: 16632408 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells.

Molecular therapy : the journal of the American Society of Gene Therapy ·Vol. 14 ·No. 2 ·2006-08-00 ·Pages 255-67

Ben-Dor I, Itsykson P, Goldenberg D, Galun E, Reubinoff BE

Abstract

Genetic modification of human embryonic stem cells (hESCs) is highly valuable for their exploitation in basic science and therapeutic applications. Here we developed lentiviral vectors (LVs) constitutively expressing a reporter and a selectable marker to enable high and homogeneous transgene expression within polyclonal hESCs. LVs carrying GFP and a downstream puromycin resistance gene, linked by the encephalomyocarditis virus (EMCV) or poliovirus internal ribosome entry sites (IRES), allowed homogeneous GFP expression after antibiotic selection. The GFP-expression levels were higher with the EMCV IRES. We also developed dual-promoter vectors harboring a reporter and an antibiotic resistance gene under the regulation of human EF1alpha and PGK1 promoters, respectively. Optimal efficiency was obtained when: (1) the reporter cassette was upstream rather than downstream of the selectable marker cassette, (2) the puromycin rather than the neomycin resistance gene was used, (3) a 5' deletion (314 bp) was created in the PGK promoter, and (4) two copies of a 120-bp element derived from the hamster Aprt CpG island were introduced upstream of the EF1alpha promoter. In summary, we developed bicistronic and novel dual-promoter LVs that enable high and homogeneous expression of transgenes by polyclonal hESCs after antibiotic selection. These vectors may provide important tools for basic and applied research on hESCs.

MeSH Terms
Animals Cell Line Cell Line, Tumor CpG Islands/genetics Cricetinae Drug Resistance/genetics Embryo, Mammalian/cytology Encephalomyocarditis virus Genetic Vectors Green Fluorescent Proteins Humans Lentivirus/genetics Phenotype Promoter Regions, Genetic Puromycin/pharmacology Stem Cells Transduction, Genetic Transgenes/genetics
Chemicals
Green Fluorescent Proteins Puromycin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ben-Dor Israel
The Hadassah Human Embryonic Stem Cell Research Center, Hadassah University Medical Center, Jerusalem 91120, Israel.
Itsykson Pavel
Goldenberg Daniel
Galun Eithan
Reubinoff Benjamin E
Article Info
Journal
Molecular therapy : the journal of the American Society of Gene Therapy
Abbr.
Mol Ther
ISSN
1525-0016
Published
2006-08-00
Epub
2006-00-24
Pages
255-67
Language
English
Region
United States
NLM ID
100890581
Subset
IM
Grants
NINDS NIH HHS · R01 NS046559-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com